Skip to main content
Premium Trial:

Request an Annual Quote

GenomSys Gains CE Mark for New Genomic Analysis Software

NEW YORK – GenomSys said Wednesday that it has received CE marking for the GenomSys Variant Analyzer. The genomic analysis software adheres to the MPEG-G genomic data representation and compression standard, which GenomSys has championed.

The GenomSys Variant Analyzer integrates curated variant databases from Varsome to automate genome annotation. According to GenomSys, a startup specializing in DNA data processing software, the use of MPEG-G helps the new product deliver faster data access time and smaller storage requirements.

"We designed GenomSys Variant Analyzer for the analysis of the vast amount of data generated by whole-exome sequencing to support geneticists in deciphering the causes of rare disorders," CSO Luca Trotta said in a statement.

The product initially will be available only in Europe. Lausanne, Switzerland-based GenomSys will show its new offering at the BioData World Congress next week in Basel, Switzerland.

GenomSys was heavily involved in the development of MPEG-G, the genomics version of the same MPEG associated with the MP3 format for digital audio and the MPEG-4 specification for compressing video files.

The company received a CE mark in March for its MPEG-G Codec Suite, a group of software tools for processing genomic data following MPEG-G.

In August, GenomSys announced a multiyear collaboration agreement with Royal Philips to codevelop software and applications based on MPEG-G.

Claudio Alberti, chief technology officer and cofounder of GenomSys, previously told GenomeWeb that with MPEG-G compression, an exome sequence needs just 1.5 gigabytes of storage, making it easily fit on a smartphone. He said that a whole genome might take up 10 to 15 GB, though current iterations of the GenomSys software have not attempted to process whole genomes yet. 

However, MPEG-G, an International Organization for Standardization specification, has been met with skepticism by some who believe that the Global Alliance for Genomics and Health (GA4GH) is the best standards-setting body for the bioinformatics world.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.